|
|
Recherche d’altérations des gènes de réparation de l’ADN dans le cancer de la prostate : mise au point pratique du Comité de cancérologie de l’association française d’urologie
G Ploussard
,
J-B Beauval
,
R Mathieu
,
E Barret
,
L Brureau
et al.
Journal articles
hal-03578125v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Salvage reirradiation for local prostate cancer recurrence after radiation therapy. For who? When? How?
M Baty
,
G Créhange
,
D Pasquier
,
X Palard
,
A Deleuze
et al.
Journal articles
hal-02280260v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease
G Ploussard
,
G Fiard
,
E Barret
,
L Brureau
,
G Créhange
et al.
Journal articles
hal-03889608v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Dose constraints for moderate hypofractionated radiotherapy for prostate cancer The French genito-urinary group (GETUG) recommendations
J Langrand-Escure
,
R de Crevoisier
,
C Llagostera
,
G Créhange
,
G Delaroche
et al.
Journal articles
hal-01807361v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
[Recent advances in the management of localized high-risk prostate cancer: An update by the Prostate Cancer Committee of the French Association of Urology]
Michael Baboudjian
,
J Beauval
,
E Barret
,
L Brureau
,
G Créhange
et al.
Progrès en Urologie, 2022, 32 (10), TT - Avancées récentes dans la prise en charge du cancer de la prostate localisé à. ⟨10.1016/j.purol.2022.04.007⟩
Journal articles
hal-03763624v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Management of metastatic disease and castration resistance
G Ploussard
,
G Roubaud
,
E Barret
,
Jb Beauval
,
L Brureau
et al.
Journal articles
hal-03889691v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|